Andrew R. Allen
2012
In 2012, Andrew R. Allen earned a total compensation of $1.3M as EVP of Clinical and Pre-Clinical Development and Chief Medical Officer at Clovis Oncology, a 92% increase compared to previous year.
Compensation breakdown
| Bonus | $123,680 |
|---|---|
| Option Awards | $784,435 |
| Salary | $384,583 |
| Other | $15,885 |
| Total | $1,308,583 |
Allen received $784.4K in option awards, accounting for 60% of the total pay in 2012.
Allen also received $123.7K in bonus, $384.6K in salary and $15.9K in other compensation.
Rankings
In 2012, Andrew R. Allen's compensation ranked 5,080th out of 11,487 executives tracked by ExecPay. In other words, Allen earned more than 55.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,080 out of 11,487 | 56th |
Division Manufacturing | 1,776 out of 4,253 | 58th |
Major group Chemicals And Allied Products | 425 out of 1,198 | 65th |
Industry group Drugs | 276 out of 920 | 70th |
Industry Pharmaceutical Preparations | 217 out of 700 | 69th |
Source: SEC filing on April 30, 2015.
Allen's colleagues
We found four more compensation records of executives who worked with Andrew R. Allen at Clovis Oncology in 2012.